378802-40-5 Usage
Uses
Used in Pharmaceutical Industry:
2-(5-Trifluoromethyl-1H-indol-3-yl)acetic acid is used as a therapeutic agent for its potential anti-inflammatory and anti-cancer properties. It has been studied for its ability to inhibit the growth of certain cancer cells and reduce inflammation in preclinical studies, making it a promising candidate for the development of new drugs to treat various diseases.
Used in Cancer Therapy:
2-(5-Trifluoromethyl-1H-indol-3-yl)acetic acid is used as a potential anti-cancer agent, targeting the inhibition of cancer cell growth. Its anti-cancer properties have been demonstrated in preclinical studies, and ongoing research aims to explore its therapeutic potential in treating various types of cancer.
Used in Inflammatory and Autoimmune Disease Treatment:
2-(5-Trifluoromethyl-1H-indol-3-yl)acetic acid is used as an anti-inflammatory agent for the treatment of inflammatory and autoimmune diseases. Its ability to reduce inflammation has been shown in preclinical studies, and further research is being conducted to determine its efficacy in treating specific conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 378802-40-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,7,8,8,0 and 2 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 378802-40:
(8*3)+(7*7)+(6*8)+(5*8)+(4*0)+(3*2)+(2*4)+(1*0)=175
175 % 10 = 5
So 378802-40-5 is a valid CAS Registry Number.
378802-40-5Relevant academic research and scientific papers
COMPOUNDS FOR THE TREATMENT OF HIV
-
Page/Page column 207, (2013/03/26)
The invention provides compounds of formula (I): or a salt thereof as described herein. The invention also provides pharmaceutical compositions comprising a compound of formula (I), processes for preparing compounds of formula (I), intermediates useful for preparing compounds of formula I and therapeutic methods for treating a Retroviridae viral infection including an infection caused by the HIV virus.
Compounds exhibiting thrombopoietin-like activities
-
, (2008/06/13)
The compounds of the invention are compounds represented by the following general formula (1): wherein E represents one selected from the group consisting of a methylidyne group and a nitrilo group, R1 represents one selected from the group consisting of optionally substituted aryl groups and optionally substituted heteroaryl groups, R2 represents one selected from the group consisting of a hydrogen atom and alkyl groups, W1 represents an amino acid residue, A represents one selected from the group consisting of a carbonyl group and a sulfonyl group, X1 represents one selected from the group consisting of optionally substituted alkylene groups and optionally substituted alkenylene groups, and p represents 0 or 1; and their pharmacologically acceptable salts, which exhibit thrombopoietin-like activity.
